MedTrace Logo

Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series

NCT05046652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2021-09-16

No results posted yet for this study

Summary

This is the first Case Studies article highlight factors determine the effectiveness of Convalescent Plasma Therapy (CPT) in Indonesia, accompanied by supporting data and images before and after the patients received the therapy. This Case Studies gives a huge contribution as CPT still on going as multicentre study and apply massively as emergency approved treatment in Indonesia.

Conditions

Interventions

BIOLOGICAL

Convalescent Plasma Therapy

In this study, eight non-intubated Covid-19 patients confirmed by real-time viral RNA PCR tests were included. Four patients had been administered two doses of 200 mL convalescent plasma (CP) and another four patients had been administered one dose of CP with an antibody titer of 1:320.

Sponsors & Collaborators

  • Primaya Hospital Tangerang Indonesia

    collaborator UNKNOWN

  • Maranatha Christian University

    lead OTHER

Principal Investigators

  • Theresia M Rahardjo, Dr · Maranatha Christian University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05046652 on ClinicalTrials.gov